Clinical trial
Safety and Local Tolerability of Prevenar in Indian Children
NCT00488800 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00488800 |
|---|---|
| Title | Safety and Local Tolerability of Prevenar in Indian Children |
| Official title | A Postmarketing Surveillance Study Evaluating the Safety and Local Tolerance of PREVENAR in Indian Children |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Pneumococcal Infections |
| Intervention type | Biological |
| Interventions | pneumococcal conjugate vaccine |
| Enrollment | 1,000 |
| Start date | Jul 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Jun 20, 2007 |
| Last update posted | Dec 28, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: